ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aβ Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan
暂无分享,去创建一个
E. Siemers | R. Dean | R. Manber | J. Jerecic | K. Sundell | K. Iverson | J. Hitchcock | E. Cline | J. Moore | C. Edgar | N. Fuin | T. Poppe | R. Barton